Nine US issuers object to OKXICE tokenized-stock plan

The objections expose the central fault line in tokenized equities: issuers, not platforms, can effectively veto listings under the exemption's per-venue objection right, and silence counting as consent gives them a low-cost way to block. The scope matters — these objections bind only OKXICE, so the precedent is venue-specific rather than a market-wide bar, which may push tokenization toward venues with fewer issuer conflicts. Whether more issuers follow, and whether the 30-day silence-as-consent default becomes the real battleground, is the open question.